These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 15770395)
1. Possible involvement of the interleukin-15 and interleukin-15 receptor system in a heightened state of lamina propria B cell activation and differentiation in patients with inflammatory bowel disease. Nishiwaki T; Ina K; Goto H; Watanabe O; Tsuzuki T; Furuta R; Ando T; Hibi K; Kusugami K J Gastroenterol; 2005 Feb; 40(2):128-36. PubMed ID: 15770395 [TBL] [Abstract][Full Text] [Related]
2. The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity. Liu Z; Yadav PK; Xu X; Su J; Chen C; Tang M; Lin H; Yu J; Qian J; Yang PC; Wang X J Leukoc Biol; 2011 Apr; 89(4):597-606. PubMed ID: 21227898 [TBL] [Abstract][Full Text] [Related]
3. Increased expression of interleukin-12 receptor beta(2) on lamina propria mononuclear cells of patients with active Crohn's disease. Stallmach A; Marth T; Adrian N; Wittig BM; Ecker KW; Schilling M; Zeitz M Int J Colorectal Dis; 2002 Sep; 17(5):303-10. PubMed ID: 12172923 [TBL] [Abstract][Full Text] [Related]
5. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. Banks C; Bateman A; Payne R; Johnson P; Sheron N J Pathol; 2003 Jan; 199(1):28-35. PubMed ID: 12474223 [TBL] [Abstract][Full Text] [Related]
6. Expression of CD45RB functionally distinguishes intestinal T lymphocytes in inflammatory bowel disease. Ten Hove T; The Olle F; Berkhout M; Bruggeman JP; Vyth-Dreese FA; Slors JF; Van Deventer SJ; Te Velde AA J Leukoc Biol; 2004 Jun; 75(6):1010-5. PubMed ID: 15020649 [TBL] [Abstract][Full Text] [Related]
7. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Heller F; Florian P; Bojarski C; Richter J; Christ M; Hillenbrand B; Mankertz J; Gitter AH; Bürgel N; Fromm M; Zeitz M; Fuss I; Strober W; Schulzke JD Gastroenterology; 2005 Aug; 129(2):550-64. PubMed ID: 16083712 [TBL] [Abstract][Full Text] [Related]
8. Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease. Danese S; Sgambato A; Papa A; Scaldaferri F; Pola R; Sans M; Lovecchio M; Gasbarrini G; Cittadini A; Gasbarrini A Am J Gastroenterol; 2005 Apr; 100(4):886-95. PubMed ID: 15784037 [TBL] [Abstract][Full Text] [Related]
9. Th1-mediated intestinal inflammation in Crohn's disease may be induced by activation of lamina propria lymphocytes through synergistic stimulation of interleukin-12 and interleukin-18 without T cell receptor engagement. Okazawa A; Kanai T; Watanabe M; Yamazaki M; Inoue N; Ikeda M; Kurimoto M; Ishii H; Hibi T Am J Gastroenterol; 2002 Dec; 97(12):3108-17. PubMed ID: 12492197 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut. Caruso R; Sarra M; Stolfi C; Rizzo A; Fina D; Fantini MC; Pallone F; MacDonald TT; Monteleone G Gastroenterology; 2009 Jun; 136(7):2270-9. PubMed ID: 19505427 [TBL] [Abstract][Full Text] [Related]